Insomnia and Endothelial Function - The HUNT 3 Fitness Study by Strand, Linn B. et al.
Insomnia and Endothelial Function – The HUNT 3 Fitness
Study
Linn B. Strand1*, Lars E. Laugsand1, Eli-Anne Skaug2, Øyvind Ellingsen2,3, Erik Madssen2,3, Ulrik Wisløff2,
Lars Vatten1, Imre Janszky1,4
1Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway, 2 KG Jebsen Center of
Exercise in Medicine, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway, 3Department of Cardiology,
St. Olavs Hospital, Trondheim, Norway, 4Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Abstract
Background: Insomnia is associated with increased risk of coronary heart disease (CHD), but the underlying mechanisms are
not understood. To our knowledge, no previous studies have examined insomnia in relation to endothelial function, an
indicator of preclinical atherosclerosis. Our aim was to assess the association of insomnia with endothelial function in a large
population based study of healthy individuals.
Methods: A total of 4 739 participants free from known cardiovascular or pulmonary diseases, cancer, and sarcoidosis, and
who were not using antihypertensive medication were included in the study. They reported how often they had
experienced difficulties falling asleep at night, repeated awakenings during the night, early awakenings without being able
to go back to sleep, and daytime sleepiness. Endothelial function was measured by flow mediated dilation (FMD) derived
from the brachial artery.
Results: We found no consistent association between the insomnia symptoms and endothelial function in multiadjusted
models, but individual insomnia symptoms may be related to endothelial function. Among women who reported early
awakenings, endothelial function may be lower than in women without this symptom (p= 0.03).
Conclusions: This study provided no evidence that endothelial function, an early indicator of atherosclerosis, is an
important linking factor between insomnia and CHD. Further studies are needed to explore the complex interrelation
between sleep and cardiovascular pathology.
Citation: Strand LB, Laugsand LE, Skaug E-A, Ellingsen Ø, Madssen E, et al. (2012) Insomnia and Endothelial Function – The HUNT 3 Fitness Study. PLoS ONE 7(12):
e50933. doi:10.1371/journal.pone.0050933
Editor: C. Mary Schooling, University of Hong Kong, China
Received July 4, 2012; Accepted October 26, 2012; Published December 6, 2012
Copyright:  2012 Strand et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science
and Technology (LBS, IJ, LEL), the Swedish Research Council and by the Swedish Council of Working Life and Social Research (IJ). FMD-data was collected in the
Fitness – study and this work was supported by grants from the Norwegian Council on Cardiovascular Disease, the Foundation for Cardiovascular Research at St.
Olav’s Hospital; the Norwegian State Railways; and Roche Norway Incorporated, and a Norwegian Research Council Grant for Outstanding Young Investigators
(UW) and the K.G. Jebsen Foundation, Norwegian Council of Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The Fitness study received funding from the commercial source Roche Norway Incorporated. This does not alter the authors’ adherence
to all the PLOS ONE policies on sharing data and materials.
* E-mail: linn.b.strand@ntnu.no
Introduction
Insomnia is a subjective feeling of having difficulties initiating or
maintaining sleep or having a feeling of non-restorative sleep [1].
Increasing evidence suggests that insomnia is associated with
subsequent coronary heart disease (CHD) in populations initially
free of heart disease [2–4]. Previously, we found a dose-dependent
association between number of insomnia symptoms and the risk of
acute myocardial infarction which was stronger in women than in
men [3]. However, the nature of this association is not yet clear.
Atherosclerosis, the underlying pathophysiological mechanism of
CHD, is known to develop decades before the first clinical
symptoms. It is possible that both insomnia and subsequent CHD
are associated with subclinical manifestations of atherosclerosis.
Since insomnia is a common and potentially treatable condition, it
is important to understand if insomnia is a causal factor or only
a correlate of CHD.
The endothelium is a thin layer of cells that forms the inner
surface of the blood vessel, forming an interface between
circulating blood and the rest of the vessel wall. Healthy
endothelial cells control the passage of materials and white blood
cells in and out of the blood stream, prevent blood clotting and
control blood pressure by releasing nitric oxide (NO) promoting
vasodilation [5]. Impaired endothelial function is an indicator of
preclinical atherosclerosis [6–8] and is characterized by decreased
activity of endothelium-derived NO, causing vasoconstriction,
platelet aggregation, and thrombus formation, all of which are
important factors in the development of atherosclerosis [9].
Endothelial function has also consistently been shown to predict
CHD [10–14].
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Figure 1. The selection process.
doi:10.1371/journal.pone.0050933.g001
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To our knowledge, no previous studies have examined insomnia
in relation to endothelial function. If an association was found, it
would provide a plausible pathway linking insomnia to CHD.
Accordingly, our aim was to assess the association of insomnia with
endothelial function when controlled for potentially confounding
factors, including age, marital status, education, sleep-disordered
breathing, and snoring, established cardiovascular risk factors such
as smoking, alcohol consumption, physical activity and BMI, and
measures of psychological distress like depression or anxiety.
Materials and Methods
Ethics Statement
All participants gave written informed consent. This research
was approved by the Norwegian research ethics committee.
Data Collection
Between October 2006 and June 2008, the entire adult
population of Nord-Trøndelag County in Norway was invited to
participate in the third wave of the Nord-Trøndelag Health Study
(HUNT-3). Approximately 54% of those who were invited,
attended the study (n= 51 000). Information was collected by
self-administered questionnaires, a clinical examination and blood
samples. Self-reported health status, use of tobacco and alcohol,
dietary items, use of medication, and information on sleep,
physical activity, and education were included in the question-
naire. Anthropometry, including measurements of height, weight,
and waist and hip circumference, was recorded, and blood
pressure and serum lipids were measured.
After excluding 20 533 participants (39%) known to have
cardiovascular or pulmonary diseases, cancer, and sarcoidosis, and
who were using antihypertensive medication, 30 513 participants
were eligible for a separate study called the Fitness study [15,16].
Table 1. Characteristics according to cumulative number of insomnia for women.
Cumulative insomnia symptoms
Variable n 0 1–2 3–4
N=2,144 N=1,468 N=566 N=110
Age (years) 2,144 49.1 (13.4) 49.5 (13.6) 51.6 (13.1)
BMI (kg/m2) 2,142 25.5 (3.7) 25.5 (4.1) 26.0 (4.4)
HADS anxiety score 2,139 3.5 (2.7) 5.4 (3.4) 6.7 (3.9)
HADS depression score 2,141 2.2 (2.2) 3.2 (2.8) 4.5 (3.3)
Physical activity index 1.986 3.7 (2.5) 3.6 (2.5) 3.3 (3.0)
FMD (%) 2,144 5.3 (4.5) 5.3 (4.4) 5.1 (4.5)
Smoking (%)
Never 1,052 53.1 43.0 48.8
Previous 581 26.3 31.5 27.4
Current 483 20.6 25.6 23.8
Marital status (%)
Never married 460 21.0 23.3 18.2
Married 1,316 62.7 59.5 54.6
Separated/divorced/widowed 365 16.3 17.1 27.3
Sleep-disordered breathing (%)
Never/almost never 2,042 97.5 94.5 96.6
Sometimes 63 2.3 4.6 3.0
Several times a week 8 0.1 0.9 0.4
Snoring (%)
Never/almost never 1,416 69.6 62.9 61.8
Sometimes 537 25.0 25.9 31.8
Several times a week 147 5.5 11.2 6.7
Alcohol intake (%)
Abstainers 865 50.7 52.5 48.9
Light drinkers 652 39.7 35.3 38.6
Moderate drinkers 139 7.8 9.5 6.8
Heavy drinkers 37 1.7 2.7 5.7
Education (%)
Primary 277 11.7 14.0 24.8
Secondary 987 45.3 47.8 49.5
Tertiary 873 43.0 38.2 25.7
doi:10.1371/journal.pone.0050933.t001
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Among them, 12 609 participants from three selected towns were
invited, and a total of 5 633 participants (44.6%) appeared at the
test site. After further exclusion of 97 participants (1.7%) with
cardiovascular disease or hypertension and 797 participants for
other reasons (e.g. pain, illness or reluctance to carry out the test),
4 739 participants completed the endothelial function test. The
participants also responded to a physical activity questionnaire.
The selection process is illustrated in Figure 1.
Insomnia
The participants answered how often during the last three
months they had experienced difficulties falling asleep at night,
repeated awakenings during the night, and early awakenings
without being able to go back to sleep, and daytime sleepiness. The
response categories were ‘‘never/almost never’’, ‘‘sometimes’’ or
‘‘several times a week’’. These questions differed slightly from the
insomnia questions asked in HUNT-2 (1996–1997) which our
previous study [3] was based upon. The questionnaire in HUNT-2
included three items related to insomnia and the participants
answered how often the last month they had difficulties falling
asleep at night, early awakenings without being able to go back to
sleep (with the response options never/occasionally, often/almost
every night), in addition to how often they suffered from poor
sleep, with the response options ‘‘never or a few times a year/1–2
times per month/about once a week/more than once a week’’.
In total, 82.9% of the participants in the fitness study (n= 3 927)
answered all the insomnia questions. The separate response rates
for the questions about difficulties falling asleep at night, repeated
awakenings during the night, early awakenings without being able
to go back to sleep, and daytime sleepiness, were 83.5% (n= 3
959), 83.4% (n= 3 950), 83.1% (n= 3 936), and 83.1% (n= 3 938),
respectively. These response rates largely reflect the overall
response rate of the HUNT-3 questionnaire that included the
insomnia questions.
Table 2. Characteristics according to cumulative number of insomnia for men.
Cumulative insomnia symptoms
Variable n 0 1–2 3–4
N=1,783 n=1,345 n=380 n=58
Age (years) 1,783 50.0 (13.2) 51.4 (13.5) 51.6 (11.3)
BMI (kg/m2) 1,782 26.6 (3.0) 26.8 (3.4) 27.1 (3.1)
HADS anxiety score 1,769 2.9 (2.5) 4.8 (3.4) 6.5 (4.1)
HADS depression score 1,769 2.6 (2.5) 4.1 (3.0) 5.7 (3.6)
Physical activity index 1,557 3.7 (2.8) 3.4 (2.6) 3.4 (3.1)
FMD (%) 1,783 4.3 (3.8) 4.0 (3.9) 5.0 (4.1)
Smoking (%)
Never 901 53.0 45.7 49.1
Previous 488 26.6 32.1 29.1
Current 366 20.4 22.2 21.8
Marital status (%)
Never married 444 25.2 23.3 31.0
Married 1,127 63.8 63.1 55.2
Separated/divorced/widowed 208 11.1 13.5 13.8
Sleep-disordered breathing (%)
Never/almost never 1,543 88.9 83.2 80.7
Sometimes 164 8.8 11.0 10.5
Several times a week 58 2.3 5.9 8.8
Snoring (%)
Never/almost never 735 42.1 38.8 44.8
Sometimes 700 40.9 36.7 25.9
Several times a week 337 17.0 24.5 29.3
Alcohol intake (%)
Abstainers 285 16.1 18.8 25.5
Light drinkers 710 42.7 41.6 36.4
Moderate drinkers 430 25.7 24.5 30.9
Heavy drinkers 255 15.5 15.1 7.3
Education (%)
Primary 191 10.2 12.5 12.1
Secondary 989 53.8 50.8 63.8
Tertiary 595 33.0 36.7 24.1
doi:10.1371/journal.pone.0050933.t002
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Information was also collected on other aspects of sleep: loud
snoring, sleep-disordered breathing, sweating while asleep, waking
up with a headache and having an uncomfortable feeling in the
legs.
Flow Mediated Dilation (FMD)
All the participants were asked to refrain from food and coffee,
smoking and dipping tobacco during the last four hours before
testing. The test was performed with the participant lying down, in
a dark room with neutral temperature and minimal noise.
Measurements were performed by ultrasonography (Vivid-i, GE
healthcare, USA) with 3 point ECG. A 12 Mhz linear array
transducer visualized the left brachial artery in the longitudinal
plane above the antecubital fossa. Baseline diameter was measured
after 10 minutes of supine rest. Arterial occlusion was created by
a cuff placed at the forearm [17,18], inflated at 250 mmHg for 5
minutes, before abruptly released. Blood flow was estimated by
pulsed Doppler velocity and recorded ten seconds after cuff
deflation. Post diameter was measured 60 sec after cuff deflation.
All arterial diameters were recorded at the peak of the R-wave in
ECG, to avoid confounding of cyclic changes in the arterial
dimension. The mean of three measurements (intima to intima)
was recorded using optical callipers with 0.1-mm resolution. Shear
rate was calculated as blood velocity (cm/s) divided by vessel
diameter (cm). The difference in baseline diameter and post
diameter was used as maximal dilation of the artery; yielding FMD
expressed as per cent change.
Physical Activity
The participants answered a physical activity questionnaire that
included questions about frequency, intensity and duration. The
frequency question was stated as ‘‘How often do you exercise?’’
with the response options ‘‘Never’’, ‘‘Less than once a week’’,
‘‘Once a week’’, ‘‘Two to three times a week’’ or ‘‘Almost every
day’’. The question related to intensity was stated as ‘‘How hard
do you exercise?’’ with the response options ‘‘No sweat or heavy
breathing’’, ‘‘Sweat and heavy breathing’’, or ‘‘Push myself to
exhaustion’’. Duration of the exercise was stated as ‘‘How long
does each session last?’’ with the response options ‘‘Less than 15
minutes’’, ‘‘Between 15 and 29 minutes’’, ‘‘Between 30 and 60
minutes’’, or ‘‘More than 60 minutes’’. Frequency, intensity and
duration were combined to form a physical activity index. We
recoded the frequency scale to approximate number of times per
week (i.e. ‘‘0’’, ‘‘0.5’’, ‘‘1’’, ‘‘2.5’’, or ‘‘5’’), the intensity scale to
‘‘1’’, ‘‘2’’, or ‘‘3’’, and the duration scale to the approximate
number of hours per session (i.e. ‘‘0.10’’, ‘‘0.38’’, ‘‘0.75’’, and
‘‘1.00’’). The physical activity index was the product of the
recoded frequency, intensity and duration scales. This method of
Table 3. Least square means and 95% confidence intervals for the insomnia symptoms and flow mediated dilation (%) in women.
Model 1 Model 2 Model 3
Mean 95% CI Mean 95% CI Mean 95% CI
Sleep initiation
Never/almost never 5.42 5.13–5.70 5.43 5.10–5.76 5.40 5.07–5.74
Occasionally 5.18 4.91–5.47 5.30 4.96–5.63 5.33 4.99–5.66
Several times/week 5.25 4.69–5.81 5.50 4.81–6.20 5.57 4.86–6.28
P- value for linear trend 0.35 0.89 0.88
P- value for quadratic trend 0.49 0.51 0.54
Repeated awakenings
Never/almost never 5.40 5.07–5.73 5.54 5.16–5.92 5.52 5.13–5.91
Occasionally 5.29 5.03–5.56 5.27 4.95–5.59 5.29 4.97–5.61
Several times/week 5.19 4.76–5.61 5.35 4.83–5.87 5.38 4.86–5.91
P- value for linear trend 0.44 0.45 0.59
P- value for quadratic trend 0.99 0.45 0.49
Early awakenings
Never/almost never 5.47 5.20–5.73 5.58 5.27–5.89 5.57 5.26–5.90
Occasionally 5.17 4.88–5.46 5.28 4.93–5.64 5.30 4.94–5.66
Several times/week 5.12 4.50–5.75 4.56 3.78–5.34 4.57 3.78–5.36
P- value for linear trend 0.15 0.02 0.03
P- value for quadratic trend 0.59 0.44 0.42
Daytime sleepiness
Never/almost never 5.27 4.91–5.62 5.26 4.83–5.69 5.19 4.76–5.63
Occasionally 5.26 5.02–5.50 5.28 5.00–5.57 5.29 5.01–5.58
Several times/week 5.68 5.15–6.22 6.04 5.43–6.65 6.17 5.54–6.80
P- value for linear trend 0.33 0.10 0.04
P- value for quadratic trend 0.28 0.12 0.10
Model 1: Adjusted for age and age squared.
Model 2: Adjusted for age, age squared, marital status, education, smoking, alcohol consumption, physical activity index, BMI, sleep-disordered breathing, snoring.
Model 3: Adjusted for the same variables as in model 2, and depression score and anxiety score.
doi:10.1371/journal.pone.0050933.t003
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Table 4. Least square means and 95% confidence intervals for the insomnia symptoms and flow mediated dilation (%) in men.
Model 1 Model 2 Model 3
Mean 95% CI Mean 95% CI Mean 95% CI
Sleep initiation
Never/almost never 4.29 4.10–4.52 4.35 4.10–4.61 4.34 4.09–4.60
Occasionally 4.27 3.97–4.57 4.33 3.99–4.66 4.33 3.99–4.67
Several times/week 3.65 2.88–4.41 3.35 2.46–4.25 3.40 2.48–4.31
P- value for linear trend 0.28 0.17 0.24
P- value for quadratic trend 0.33 0.11 0.12
Repeated awakenings
Never/almost never 4.15 3.87–4.42 4.18 3.88–4.48 4.18 3.88–4.48
Occasionally 4.33 4.10–4.60 4.39 4.08–4.69 4.39 4.08–4.69
Several times/week 4.34 3.86–4.81 4.38 3.85–4.91 4.38 3.85–4.91
P- value for linear trend 0.38 0.40 0.29
P- value for quadratic trend 0.66 0.63 0.65
Early awakenings
Never/almost never 4.20 3.96–4.45 4.21 3.94–4.47 4.16 3.89–4.43
Occasionally 4.19 3.90–4.49 4.26 3.93–4.59 4.29 3.96–4.63
Several times/week 4.88 4.02–5.50 4.99 4.31–5.67 5.13 4.43–5.82
P- value for linear trend 0.18 0.10 0.04
P- value for quadratic trend 0.12 0.18 0.16
Daytime sleepiness
Never/almost never 4.45 4.13–4.77 4.48 4.13–4.83 4.45 4.09–4.80
Occasionally 4.16 3.93–4.39 4.17 3.91–4.43 4.17 3.91–4.43
Several times/week 4.14 3.58–4.70 4.40 3.75–5.06 4.48 3.80–5.16
P- value for linear trend 0.18 0.41 0.58
P- value for quadratic trend 0.50 0.24 0.21
Model 1: Adjusted for age and age squared.
Model 2: Adjusted for age, age squared, marital status, education, smoking, alcohol consumption, physical activity index, BMI, sleep-disordered breathing, snoring.
Model 3: Adjusted for the same variables as in model 2, and depression score and anxiety score.
doi:10.1371/journal.pone.0050933.t004
Table 5. Least square means and 95% confidence intervals for the cumulative insomnia symptoms and flow mediated dilation (%).
Model 1 Model 2 Model 3
Insomnia symptoms n Mean 95% CI Mean 95% CI Mean 95% CI
Women
0 1,468 5.31 5.08–5.53 5.33 5.06–5.59 5.32 5.05–5.59
1–2 566 5.29 4.93–5.65 5.57 5.12–6.01 5.61 5.15–6.06
3–4 110 5.28 4.46–6.11 5.16 4.17–6.14 5.26 4.26–6.26
P- value for linear trend 0.92 0.72 0.55
P- value for quadratic trend 0.99 0.35 0.35
Men
0 1,345 4.28 4.08–4.49 4.30 4.07–4.52 4.27 4.04–4.50
1–2 380 4.04 3.65–4.42 4.14 3.69–4.58 4.20 3.75–6.66
3–4 58 5.01 4.03–5.99 5.15 4.04–6.26 5.32 4.18–6.46
P- value for linear trend 0.96 0.65 0.39
P- value for quadratic trend 0.06 0.11 0.11
Model 1: Adjusted for age and age squared.
Model 2: Adjusted for age, age squared, marital status, education, smoking, alcohol consumption, physical activity index, BMI, sleep-disordered breathing, snoring.
Model 3: Adjusted for the same variables as in model 2, and depression score and anxiety score.
doi:10.1371/journal.pone.0050933.t005
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calculating physical activity level has been reported and validated
previously [19].
Clinical Information
Clinical information on weight, height, and blood pressure was
collected by trained nurses. Systolic and diastolic blood pressure
was measured three times (Dinamap 845XT Criticon) and the
average of the second and third measurement was used in the
analysis. Height was measured to the nearest 1 cm and weight to
the nearest 0.5 kg. The participants wore light clothes and no
shoes during these measurements. Body mass index (BMI) was
calculated as weight (in kilograms) divided by height squared (in
meters).
Socio-demographic (i.e. sex, age, and marital status) and lifestyle
factors (i.e. smoking and alcohol intake) were collected by
questionnaires. Marital status was categorised into never married,
married, or separated/divorced/widowed, and education was
categorised into whether they had completed primary and lower
secondary school, upper secondary school, or university. The
participants were defined as either never smokers, previous
smokers or current smokers. In relation to alcohol consumption,
the participants reported how many glasses of beer, wine and
spirits they usually consumed over a two-week period. From this
information, we categorised the participants into abstainers, light
drinkers (0–1 drinks per day), moderate drinkers (above 1 but
below 2 drinks per day), or heavy drinkers (2 or more drinks per
day).
Anxiety and Depression
To assess symptoms of anxiety and depression, the Hospital
Anxiety and Depression Scale (HADS) was used. The question-
naire consists of 14 questions (7 for anxiety and 7 for depression)
with a four point scale ranging from 0 (not at all) to 3 (very often).
Responses are summed to provide separate scores for symptoms of
anxiety and depression with possible scores ranging from 0 to 21
for each scale. Higher scores indicate greater likelihood of
depression or anxiety [20]. The Hospital Anxiety and Depression
Scale is a useful tool in the assessment of symptom severity both in
hospital settings and in primary health care [21]. The psycho-
metric properties of the scale have been validated previously in the
HUNT study [22].
Participant Characteristics
Characteristics of the participants according to cumulative
number of insomnia symptoms are presented in Table 1 and
Table 2. For both women and men, participants with insomnia
symptoms tended to be older and heavier than participants
without insomnia symptoms. They also had lower physical activity
level and were less educated. In both sexes, depression and anxiety
scores increased with increasing number of insomnia symptoms.
Compared to women without insomnia symptoms, women with
insomnia symptoms were more likely to be heavy drinkers and
separated, divorced or widowed. For men, but not in women, the
prevalence of insomnia symptoms increased with increasing
severity of sleep-disordered breathing and snoring.
Statistical Analysis
The data were analysed using general linear models. We
assessed each insomnia symptom using the original response
categories. First, we adjusted for both age and square of age
(Model 1). In the next model, we further adjusted for marital
status, education, smoking, alcohol consumption, BMI, physical
activity index, sleep-disordered breathing, and snoring (Model 2).
Lastly, we included depression score, and anxiety score in addition
to factors included in Model 2 (Model 3). We calculated least
square means of FMD with corresponding 95% confidence
intervals for each category of insomnia symptoms. Participants
with no insomnia complaints were the reference group. In analyses
of trend, we assigned a value from 1–3 to the insomnia variables
representing ‘‘never/almost never’’, ‘‘sometimes’’, and ‘‘several
times a week’’, respectively. We treated these variables as
continuous variables to test for linear trend. In separate analyses,
we included a quadratic term to assess non-linear trends.
The insomnia symptoms were also dichotomized so we could
assess the association of cumulative number of symptoms with
FMD. Participants with the most frequent symptoms (i.e. those
experiencing the symptom several times a week) were defined as
having the respective symptom. To test the cumulative association
of insomnia symptoms, we calculated the least square mean
associated with increasing number of dichotomized insomnia
symptoms (i.e. 0, 1–2, and 3–4). In this analysis, we excluded
participants with missing information on one or more of the
insomnia variables.
As a sensitivity analysis we repeated the original analysis after
excluding participants who reported sleep-disordered breathing.
To assess possible effect modification we conducted stratified
analyses as well as performed formal tests of interactions with sex,
age (i.e. below and above 50 years), and BMI (i.e. below and above
30 kg/m2).
In these analyses, we found indication for a possible sex
difference in the association between some of the insomnia
symptoms and FMD. The p-values for an interaction by gender in
relation to sleep initiation, frequent awakenings, early awakenings
and daytime sleepiness were 0.565, 0.172, 0.002 and 0.036,
respectively. Because of these findings, and due to the well-known
sex differences in endothelial function and in the prevalence of
insomnia [16,23,24] all models were run separately for women
and men.
All statistical analyses were conducted using STATA 12 for
Windows (Stata corp., College Station Texas).
Results
We found no evidence for an association of having difficulties
initiating sleep or maintaining sleep with FMD in either women
(Table 3) or men (Table 4).
Women experiencing early awakenings several times/week had
an estimated FMD of 4.56% (95% CI 3.78–5.34) compared to
5.58% (95% CI 5.27–5.89) in women without the symptom after
adjusting for age, marital status, education, smoking, alcohol
consumption, self-reported physical activity, body mass index
(BMI), sleep-disordered breathing, and snoring (p for
trend= 0.02). Further adjustment for anxiety and depression did
not change the estimates.
Among men, there was no apparent association between
daytime sleepiness and estimated FMD in any of the models.
For women however, we found that those who reported a feeling
of daytime sleepiness several times/week had an estimated FMD
of 6.17% (95% CI 5.54–6.80) compared to 5.19% (95% CI 4.76–
5.63) in other women (fully adjusted model, p for trend= 0.04).
For both women and men, we found no consistent associations
between the cumulative number of insomnia symptoms and FMD
in any of the models (Table 5). We obtained similar results after
excluding participants who reported sleep-disordered breathing
sometimes and several times/week (n = 293, results not shown).
We found no evidence of effect modification of age or BMI for
any of the symptoms in any of the models (results not shown).
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Discussion
To the best of our knowledge, this is the first study of insomnia
and endothelial function. Overall, we found no consistent
associations between insomnia and endothelial function. Thus,
we could not provide clear evidence for the early indicator of
atherosclerosis acting as a link between insomnia and CHD.
A few small-scale experimental studies have examined the
possible vascular effects of acute sleep deprivation [25,26]. In those
studies, the investigators observed a decrease in vascular reactivity
after short term sleep deprivation.
Some previous studies have examined the association of more
chronic sleep deprivation with endothelial function [27,28]. One
study [28] reported that mean endothelial function had decreased
from 7.4% to 3.7% before and after a 4-week period with chronic
sleep deprivation. Another study [27] found an inverse relation
between mean sleep duration and forearm blood flow responses to
infusion of an endothelin receptor antagonist, indicating that
habitual short sleep duration is associated with impaired endo-
thelial function. However, both studies were small and did not
provide sex-specific results. Also, there was no available in-
formation on anxiety and depression, two factors that are
potentially important confounders in relation to insomnia and
cardiovascular diseases, since anxiety and depression are both
related to insomnia [29,30] and to the risk of cardiac events [31].
In our previous analyses of the HUNT-2 study, we found that
experiencing insomnia symptoms increased the risk of incident
AMI [3]. Recently, endothelial function was collected in HUNT-
3, and we were able to explore whether endothelial dysfunction
could be a mechanism behind the previously observed association
between insomnia and AMI. However, the HUNT-3 study does
not have an adequate follow time yet to investigate insomnia and
AMI risk in this population.
Our analyses of individual insomnia symptoms suggest that
some of the symptoms might be related to endothelial function,
and that this relation might differ by sex. Among women we
observed an inverse association of early awakenings with
endothelial function, but there was an opposite trend among
men. Also, women that reported daytime sleepiness had a higher
FMD than other women. Of note, a large study reported
a reduction in all-cause mortality associated with increasing
frequency of insomnia [32]. Therefore, some aspects of insomnia
might actually have a protective effect in certain subgroups.
Nevertheless, the positive association between daytime sleepiness
and endothelial function that we found among women was
unexpected and warrants further evaluation in future studies.
The nature of the association of insomnia and CHD is unclear,
and it is unknown whether insomnia is a cause or only a marker of
increased risk. Endothelial dysfunction, an indicator of athero-
sclerosis in its earlier, preclinical stage, had no overall consistent
association with insomnia in our study. However, insomnia might
have an impact on CHD through other pathways, including
influence on plaque stability via increasing the level of pro-
inflammatory cytokines or on thrombosis via increasing the level of
pro-coagulatory factors [33–38]. The latter two mechanisms, in
contrast to endothelial dysfunction refer to a late stage of
atherosclerosis. The increased CHD risk apparent in persons
suffering from insomnia [2–4,39], regardless of its exact nature,
suggests that insomniacs and their doctors should be aware of
increased cardiovascular risk and should be able to recognize
symptoms and early manifestations of CHD in an effort to forestall
its serious consequences.
Limitations
Despite of its clear strengths that include the large sample size,
the population based design and the use of directly measured
FMD, our study also has some important limitations.
It was based on self-reported measures of sleep, and objective
measures (i.e. polysomnography) were not available. Insomnia is
defined as a subjective feeling of having difficulties falling asleep,
remaining asleep or receiving restorative sleep [1,24] and thus,
such problems are not routinely evaluated by polysomnography
[40]. However, our evaluation largely reflects the DSM-IV criteria
of insomnia [1].
We did not evaluate chronic insomnia symptoms. If an
association with endothelial function only result from prolonged
exposure to insomnia symptoms, not to only recent exposure, and
subjects in our study belonged mainly to the latter group, the
association between insomnia and vascular dysfunction might be
diluted and difficult to detect.
Information about sleep duration was not available in our study.
However, insomnia is a different condition than short sleep
duration [32] and people with insomnia symptoms could have
normal or long duration of sleep [41]. Also, some people with
short sleep duration may not have any insomnia symptoms
because there is a large variation between individuals in the
duration of sleep that is needed for physiological and psychological
restoration [42,43]. It is also important to recognize that insomnia
provides additional information on the quality of sleep. From one
study it was reported that the increased risk of CHD associated
with short duration of sleep was greatest among those with a sleep
disturbance [44]. Thus, only accounting for sleep duration will
miss information about subjective quality of sleep that may be
important in the assessment of its harmful effects.
In our study, we restricted to individuals free of cardiovascular
diseases (CVD) and hypertension. This restriction, as a condition-
ing on common consequences of cardiovascular risk factors, might
introduce a collider stratification bias, which is a frequent problem
in similar cross sectional studies [45,46].
This study may also be subject to self-selection bias. Only 54%
of the eligible population responded to the HUNT-3 study and
only 44.6% of those invited to the Fitness study chose to
participate in the FMD testing. Thus, it might be suspected that
only the healthiest accepted the invitation. However, by compar-
ing the participants in the fitness study with a healthy sample of the
total HUNT population (i.e. free from cardiovascular or pulmo-
nary diseases, cancer, or sarcoidosis), it was confirmed that the
fitness participants were not considerably different from other
healthy participants in the HUNT Study with regard to self-
reported and measured health variables [15].
We cannot exclude the possibility that the reported insomnia
symptoms are caused by underlying pathology and that the
insomnia symptoms are secondary to that condition. Because
participants in the HUNT-3 study with known cardiovascular or
pulmonary diseases, cancer, sarcoidosis, and users of antihyper-
tensive medication were ineligible for our study however, this
possibility has been minimised.
It is possible that some of the covariates included in models 2
and 3 may act as mediators in the association of insomnia with
endothelial function. For example alcohol consumption near bed
time may be used as sleep aid. However, adjustment for these
factors had very limited impact on the regression coefficients.
Our study was performed on an apparently healthy, socio-
economically homogenous population and the results cannot be
directly generalized to less healthy populations or to countries on
different latitudes, different socioeconomic status or with different
sleeping habits.
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Conclusions
In this large population based study of apparently healthy
individuals, we found no consistent association of insomnia with
FMD. Thus, endothelial function did not provide a clear link
between insomnia and subsequent CHD. As it is an early indicator
of preclinical atherosclerosis and a significant determinant of
cardiovascular diseases, our findings may be important in the
complex interrelation between sleep and the cardiovascular
system. The sex-specific differences related to some of the
insomnia symptoms warrant further investigation.
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